新的心血管代谢风险因素机制和治疗机会
Paul C Evans1, Gemma Vilahur2, Petra Kleinbongard3
1Centre for Microvascular Research, William Harvey Research Institute, Barts and the London Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK.
European heart journal
|March 6, 2026
概括
代谢障碍显著增加心血管风险. 了解代谢药物如何影响心脏健康对于开发针对这些普遍疾病的新疗法至关重要.
科学领域:
- 心脏病学 心脏病学
- 代谢障碍 代谢障碍 代谢障碍
- 药理学 药理学是指药理学的学科.
背景情况:
- 肥胖,2型糖尿病和脂质失调等代谢障碍是导致心血管疾病风险的主要因素.
- 这些情况在全球范围内已经达到流行病的程度.
- 新兴研究强调了代谢药物的有益心血管作用,表明了复杂的代谢-心脏相互作用.
研究的目的:
- 为分子和细胞途径提供全面的概述,将代谢功能障碍与心血管疾病联系起来.
- 阐明代谢药物对心血管结果的作用机制.
- 识别知识缺口,并建议未来的治疗开发研究方向.
主要方法:
- 这是一个科学声明,综合了当前的研究.
- 它涉及对新出现的分子和细胞通路的审查.
- 欧洲心脏病学会 (ESC) 的专家共识影响了内容.
主要成果:
- 代谢异常与血管和心脏病理密切相关.
- 许多代谢药物对心血管健康的精确分子机制尚未完全理解.
- 对于基础研究来弥合这一知识差距,有着至关重要的需求.
结论:
- 进一步的研究对于了解代谢障碍和心血管疾病的生物学是必不可少的.
- 阐明治疗机制将使合理的药物开发成为可能.
- 本声明旨在促进在有代谢功能障碍的患者心血管疾病的预防和管理方面的创新.
相关概念视频
Coronary Artery Disease I: Introduction
1.4K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.4K
Atherosclerosis III: Management
538
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
538
Cardiovascular Drugs: Classification based on Therapeutic Indications
4.4K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.4K
Pharmacogenomics: Identification of New Drug Targets
55
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
55
Regulation of the Cardiovascular System
4.6K
The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
4.6K
Coronary Artery Disease II: Pathophysiology
847
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
847
